[Form 4/A] LION COPPER & GOLD CORP. Amended Insider Trading Activity
Charles Travis Naugle, a director of Lion Copper & Gold Corp. (LCGMF), reported an open-market purchase of 65,000 common shares at $0.06 per share on 02/04/2025. After that transaction he directly beneficially owns 1,398,333 common shares and indirectly owns 833,334 common shares through Redhill Energy LLC. The filing also discloses several outstanding derivative positions exercisable into common shares at a $0.06 exercise price: options exercisable 12/10/2024 (3,750,000 shares), options exercisable 07/21/2023 (780,000 shares and 4,385,965 shares with differing expirations), and multiple warrants held indirectly across related entities and IRAs totaling several million underlying common shares. These items show direct purchase activity plus significant option and warrant exposures at the same strike price.
- Director purchase reported: Acquisition of 65,000 common shares at $0.06 shows insider buying.
- Aligned exercise price across instruments: Options and warrants share a $0.06 strike, simplifying dilution analysis.
- None.
Insights
TL;DR: Director purchase is routine insider activity; sizeable derivative positions at the same strike suggest concentrated exposure but no new governance actions disclosed.
The Form 4/A shows a small direct purchase of 65,000 common shares at $0.06 and significant derivative holdings exercisable into common shares at the same $0.06 strike. The mix of direct, indirect and IRA-held warrants indicates related-party and personal exposure to equity upside rather than corporate governance changes. No departures, new grants with atypical terms, or related-party transactions beyond indirect holdings are disclosed. Impact on shareholder control appears minimal given disclosed totals versus unknown company float.
TL;DR: Insider bought shares and maintains large in-the-money options/warrants at $0.06; materiality depends on company share count and market context not provided.
The filing documents a purchase and multiple derivative instruments all with a $0.06 exercise/conversion price. Options and warrants underlying millions of common shares could be dilutive if exercised, but the filing provides no company-wide share count or market capitalization to assess dilution percentage. Transaction sizes should be evaluated relative to outstanding shares and public float to judge investor impact.